Apparatus and methods for biosynthetic production of cannabinoids
The present invention provides an apparatus and methods for producing tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) and cannabichromenic acid (CBCA) in different ratios. The apparatus comprises:(i) a bioreactor comprising (a) an automated supply system configured to deliver a first automated supply of cannabigerolic acid (CBGA), a cannabinoid acid synthase, and a reaction mixture; and (b) a second automated system to cease the reaction; (ii) a controller configured to modify a property of the reaction mixture to produce the desired products; and (iii) an extractor configured to recover the tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) or cannabidiolic acid (CBDA) and cannabichromenic acid.
1. An apparatus for producing tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) in different ratios or cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) in different ratios, wherein the apparatus comprises: (i) a bioreactor comprising (a) an automated supply system configured to deliver a first automated supply of cannabigerolic acid (CBGA), a cannabinoid acid synthase, and a reaction mixture; and (b) a second automated system to cease the reaction; (ii) a controller configured to modify a property of the reaction mixture, wherein the property of the reaction mixture is one or more properties of a reaction solvent, an ionic strength of a reaction medium, a temperature of the reaction, a reaction pressure, a viscosity of the reaction mixture, a pH of the reaction mixture, a concentration of the reagents, or a concentration of an amphiphilic compound to produce tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) when the cannabinoid synthase is a tetrahydrocannabinolic acid synthase (THCA synthase) that comprises a nucleic acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 3 or a variant or a fragment thereof, or a nucleic acid sequence that encodes a polypeptide comprising SEQ ID NO: 2 or SEQ ID NO: 4, or a variant or a fragment thereof; or cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) when the cannabinoid synthase is a cannabinolic acid synthase (CBDA synthase) that comprises a nucleic acid sequence represented by SEQ ID NO: 5 or SEQ ID NO: 7 or a variant or a fragment thereof, or a nucleic acid sequence that encodes a polypeptide comprising SEQ ID NO: 6 or SEQ ID NO: 8 or a variant or a fragment thereof; and (iii) an extractor configured to recover the tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) or the cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) so produced.
2. The apparatus of claim 1 , wherein the cannabinoid synthase is immobilized on a solid support.
3. The apparatus of claim 1 , wherein the cannabinoid synthase is a natural or a synthetic cannabinoid synthase.
4. The apparatus of claim 3 , wherein the cannabinoid synthase is a recombinant cannabinoid synthase, and the apparatus further comprises a system to produce the recombinant cannabinoid synthase.
5. The apparatus of claim 4 , wherein the system to produce the recombinant cannabinoid synthase comprises a system to overexpress the cannabinoid synthase.
6. The apparatus of claim 5 , wherein the system overexpresses the cannabinoid synthase in yeast or in Escherichia coli.
7. The apparatus of claim 1 , wherein the reaction mixture comprises a solvent and an amphiphilic compound.
8. The apparatus of claim 7 , wherein the solvent is one or more of dimethyl sulfoxide (DMSO), dimethyl formamide (DMF) and iso-propoyl alcohol, and wherein the amount of the solvent in the reaction mixture is between 5% and 30% (w/v).
9. The apparatus of claim 7 , wherein the amphiphilic compound is a surfactant or a cyclodextrin.
10. The apparatus of claim 9 , wherein the cyclodextrin is α-cyclodextrin, β-cyclodextrin or γ-cyclodextrin.
11. The apparatus of claim 10 , wherein the cyclodextrin is sulfobuthylether β-cyclodextrin sodium salt or randomly methylated β-cyclodextrin, and the concentration of cyclodextrin in the reaction mixture is between 2 and 28 mg/ml.
12. The apparatus of claim 11 , wherein the concentration of cyclodextrin in the reaction mixture is 8 mg/ml.
13. The apparatus of claim 1 , wherein the tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) or cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) so produced are single enantiomers with an enantiomeric purity of at least 95%.
14. The apparatus of claim 9 , wherein the cannabinoid synthase is THCA synthase and the amphiphilic compound is cyclodextrin, and wherein the mass: mass ratio of cyclodextrin to cannabigerolic acid (CBGA) is 28:1 or the molar ratio of cyclodextrin to cannabigerolic acid (CBGA) is 7.3:1.
15. The apparatus of claim 14 , wherein 98% of the cannabigerolic acid CBGA is converted into tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) within two hours.
16. The apparatus of claim 9 , wherein the cannabinoid acid synthase is CBDA synthase and the amphiphilic compound is cyclodextrin, and wherein the mass: mass ratio of cyclodextrin to the cannabigerolic acid (CBGA) is 11:1 or the molar ratio of cyclodextrin to the cannabigerolic acid (CBGA) is 4:1.
17. The apparatus of claim 16 , wherein 98% of the cannabigerolic acid (CBGA) is converted into cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) within two hours.
18. The apparatus of claim 1 , wherein the property of the reaction mixture is the pH of the reaction mixture, and wherein the controller modifies the pH in a range from about 3.8 to about 8.0.
19. The apparatus of claim 1 , wherein the property of the reaction mixture is the concentration of the amphiphilic compound, and wherein the controller modifies the concentration of the amphiphilic compound in the reaction mixture between 2 and 28 mg/ml.